Work-related sickness absences and mandatory occupational health surveillance

Mortelmans, Anna Katharina; Donceel, Peter; Lahaye, Diederik; Bulterys, Simon

doi:10.1093/occmed/kqn089

Cited by 4 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Um aspecto importante a ser focalizado é o presenteísmo, ou especificamente para os trabalhadores informais, o tipo de rearranjos familiares e o papel do apoio social para garantia da sobrevivência em caso de incapacidade para o trabalho. Além disso, os dados são autorreferidos pelos trabalhadores e se sustentam em suas percepções e julgamentos subjetivos, o que pode estar sujeito a vieses vários, apesar de evidências em contrário 27 .…”

Section: Discussionunclassified

Faltas ao trabalho por problemas de saúde na indústria

Yano

Santana

2012

Cad. Saúde Pública

View full text Add to dashboard Cite

Section: Discussionunclassified

Faltas ao trabalho por problemas de saúde na indústria

Yano

Santana

2012

Cad. Saúde Pública

View full text Add to dashboard Cite

“…However, the long-term efficacy of an IPS has not yet been studied in terms of SA. While the efficacy in terms of decreasing SA during one year of follow-up was large in RCT I, this could indicate that the intervention has lasting effects on help seeking behavior, which could possibly decrease SA over a long time period (23)(24)(25). Especially since one might assume that early contact with the occupational physician (OP) could result in sustainable work adjustments or other improvements in working conditions.…”

mentioning

confidence: 99%

Efficacy of an indicated prevention strategy on sickness absence and termination of the employment contract: a 5-year follow-up study

Klasen¹,

Amelsvoort²,

Jansen³

et al. 2021

Scand J Work Environ Health

View full text Add to dashboard Cite

Objective: It was shown that an indicated prevention strategy (IPS), based on screening and early intervention, can considerably decrease future risk of long-term sickness absence (LTSA>28 days) over one year. Given the nature of the interventions, the potential of an effect extending beyond the original one year of follow-up might be present. This study aims to determine the efficacy of this IPS on LTSA and termination of employment contract over five years by extended follow up of IPS trials. Methods: Company records on sickness absence and termination of employment contract over five years were used from two randomized controlled trials (RCT) on the efficacy of the IPS (RCT I employees at high-risk for LTSA: intervention: N=263; RCT II high-risk employees with concurrent mild depressive complaints: intervention: N=139). Survival analysis was used to model time until the first LTSA episode and termination of employment contract. Results: RCT I showed a decrease of 43.2 days of sickness absence (P=0.05) and a lower 5-year risk of LTSA in the intervention, as compared to the control group [hazard ratio (HR) 0.61, 95% confidence interval (CI) 0.41–0.90], however no considerable impact on employment contract (HR 0.85, 95% CI 0.54–1.35) (intention-to-treat, ITT). For RCT II, we found no large difference in days of SA and no difference in LTSA risk over five years (HR 1.31, 95% CI 0.70–2.47), whereas the risk of termination of the employment contract was lower (HR 0.62, 95% CI 0.39–0.99) (ITT). Conclusion: Effects of the IPS were observed over five years, albeit differential between the two approaches. A combination of elements of both interventions might lead to optimal results but needs further study.

show abstract